Brenda J. Ernst, M.D.

  1. Hematologist / Oncologist

المنشورات

  1. Hammond JB, Scott DW, Kosiorek HE, Parnall TH, Gray RJ, Ernst BJ, Northfelt DW, McCullough AE, Ocal IT, Pockaj BA, Cronin PA. Characterizing Occult Nodal Disease Within a Clinically Node-Negative, Neoadjuvant Breast Cancer Population. Clin Breast Cancer. 2021 Jul 25 Epub 2021 July 25
    View PubMed
  2. Singh KP, Kober KM, Ernst B, Sachdev J, Brewer M, Zhu Q, Gu H, Melisko M, Paul SM, Cooper BA, Hammer M, Conley YP, Levine JD, Miaskowski C. Multiple Gastrointestinal Symptoms Are Associated With Chemotherapy-Induced Nausea in Patients With Breast Cancer. Cancer Nurs. 2021 Jun 28 Epub 2021 June 28
    View PubMed
  3. Hammond JB, Parnall TH, Scott DW, Kosiorek HE, Pockaj BA, Ernst BJ, Northfelt DW, McCullough AE, Ocal IT, Cronin PA. Gauging the efficacy of neoadjuvant endocrine therapy in breast cancer patients with known axillary disease. J Surg Oncol. 2020 Jun 7 Epub 2020 June 07
    View PubMed
  4. Ertz-Archambault NM, Rogoff LB, Kosiorek HE, Ernst BJ, Anderson KS, Pockaj BA, Gray RJ, Northfelt DW. Depomedroxyprogesterone acetate therapy for hot flashes in survivors of breast cancer: no unfavorable impact on recurrence and survival. Support Care Cancer. 2020 May; 28 (5):2139-2143 Epub 2019 Aug 11
    View PubMed
  5. McDonald BR, Contente-Cuomo T, Sammut SJ, Odenheimer-Bergman A, Ernst B, Perdigones N, Chin SF, Farooq M, Mejia R, Cronin PA, Anderson KS, Kosiorek HE, Northfelt DW, McCullough AE, Patel BK, Weitzel JN, Slavin TP, Caldas C, Pockaj BA, Murtaza M. Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer. Sci Transl Med. 2019 Aug 7; 11 (504)
    View PubMed
  6. Padrnos L, Ernst B, Dueck AC, Kosiorek HE, Ginos BF, Toro A, Johnston PB, Habermann TM, Leis JF, Mikhael JR, Nowakowski GS, Colgan J, Porrata L, Ansell SM, Witzig TE, Reeder C. A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma. Clin Lymphoma Myeloma Leuk. 2018 Oct; 18 (10):664-672.e2 Epub 2018 June 15
    View PubMed
  7. Shanavas M, Popat U, Michaelis LC, Fauble V, McLornan D, Klisovic R, Mascarenhas J, Tamari R, Arcasoy MO, Davies J, Gergis U, Ukaegbu OC, Kamble RT, Storring JM, Majhail NS, Romee R, Verstovsek S, Pagliuca A, Vasu S, Ernst B, Atenafu EG, Hanif A, Champlin R, Hari P, Gupta V. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors. Biol Blood Marrow Transplant. 2016 Mar; 22 (3):432-40 Epub 2015 Oct 19
    View PubMed
  8. Ernst B, Anderson KS. Immunotherapy for the treatment of breast cancer. Curr Oncol Rep. 2015 Feb; 17 (2):5
    View PubMed